Vimarsana
Biggest News Aggregation in the World

Page 9 - Sam Eiber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sam Eiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sam Eiber Today - Breaking & Trending Today

Abbott to Buy Cardiovascular Systems for $890M | Twin Cities Business - Vimarsana News

Abbott to Buy Cardiovascular Systems for $890M | Twin Cities Business

New Brighton-based Cardiovascular Systems is slated to bring new, complementary products to Abbott's existing offerings.

Source: tcbmag.com
Analysts stay neutral on Embecta, await patch pump development - Vimarsana News

Analysts stay neutral on Embecta, await patch pump development

BTIG analysts maintained their neutral rating for Embecta (Nasdaq:EMBC) ahead of the company's fourth-quarter earnings report next week.

Related Topics:
Sam EiberMarie Thibault
Masimo will turn millions of home sound systems into health hubs - Vimarsana News

Masimo will turn millions of home sound systems into health hubs

Masimo is rolling out a software upgrade that will enable millions of high-end home entertainment systems to become health information hubs. 

Masimo stock down on supply chain, economic headwinds - Vimarsana News

Masimo stock down on supply chain, economic headwinds

Masimo reported third-quarter results that beat the consensus forecast on Wall Street — but it held down its Q4 guidance.

Analysts see multi-year transition to growth for Embecta - Vimarsana News

Analysts see multi-year transition to growth for Embecta

Embecta (Nasdaq:EMBC), the BD diabetes business spinoff, may take a few years to move into a growth phase, analysts say.

Related Topics:
Sam EiberMarie Thibault